Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer

Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation

Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535

Molecular mechanisms and clinical applications of angiogenesis

Carmeliet, P., & Jain, R. K. (2011) · Nature · doi:10.1038/nature10144 · Cited by 5,467

Macrophage Diversity Enhances Tumor Progression and Metastasis

Qian, B., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,349

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617

Macrophage activation and polarization

Martinez, F. O. (2008) · Frontiers in Bioscience · doi:10.2741/2692 · Cited by 3,160

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617

Hypoxia-inducible factors and the response to hypoxic stress

Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Rosenberg, S. A., Yang, J. C., Sherry, R. M., Kammula, U. S., Hughes, M. S., Phan, G. Q., Citrin, D. E., Restifo, N. P., Robbins, P. F., Wunderlich, J. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0116 · Cited by 2,208

Immunosuppressive networks in the tumour environment and their therapeutic relevance

Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1

Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595

MicroRNAs and Tumor Vasculature Normalization: Impact on Anti-Tumor Immune Response

Matejuk, A., Collet, G., Nadim, M., Grillon, C., & Kiéda, C. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0231-4 · Cited by 30

Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1)

Raggi, F., & Bosco, M. C. (2020) · Cancers · doi:10.3390/cancers12051337 · Cited by 30

Pre-treatment Haemoglobin and Peripheral Blood Lymphocyte Count as Independent Predictors of Outcome in Carcinoma of Cervix

Hoskin, P., Rojas, A. M., Peiris, S. N., Mullassery, V. M., & Chong, I. Y.-S. (2014) · Clinical Oncology · doi:10.1016/j.clon.2013.11.023 · Cited by 30

Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy

Li, W., Peng, A., Wu, H., Quan, Y., Li, Y., Lu, L., & Cui, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601497 · Cited by 29

The platelet–cancer loop in myeloproliferative cancer. Is thrombocythemia an enhancer of cancer invasiveness and metastasis in essential thrombocythemia, polycythemia vera and myelofibrosis?

Hasselbalch, H. C. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.07.006 · Cited by 29

The mechanopathology of the tumor microenvironment: detection techniques, molecular mechanisms and therapeutic opportunities

Angeli, S., Neophytou, C., Kalli, M., Stylianopoulos, T., & Mpekris, F. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1564626 · Cited by 34

Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature

Shi, S., Chen, L., & Huang, G. (2013) · Medical Oncology · doi:10.1007/s12032-013-0698-1 · Cited by 27

Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors

Zhou, Y. J., Liu, Z., Yu, A., Zhao, G., & Chen, B. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s494670 · Cited by 30

An update on the clinical trial research of immunotherapy for glioblastoma

Zhou, Y., Shi, F., Zhu, J., & Yuan, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582296 · Cited by 31

Role of tumor hypoxia in acquisition of resistance to microtubule-stabilizing drugs

Das, V., Štěpánková, J., Hajdúch, M., & Miller, J. H. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.02.001 · Cited by 26

Genetic Regulation of Fate Decisions in Therapeutic T Cells to Enhance Tumor Protection and Memory Formation

Veliça, P., Zech, M., Henson, S. M., Holler, A., Manzo, T., Pike, R., Sousa, P. S. E., Zhang, L., Schiedlmeier, B., Pulè, M. A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3283 · Cited by 25

Sodium–glucose transporter as a novel therapeutic target in disease

Yamazaki, Y., Harada, S., & Tokuyama, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.01.003 · Cited by 25

Immune Modulation in Lung Cancer: Current Concepts and Future Strategies

Gaissmaier, L., & Christopoulos, P. (2020) · Respiration · doi:10.1159/000510385 · Cited by 24

Macrophage HIF‐2α regulates tumor‐suppressive Spint1 in the tumor microenvironment

Susen, R. M., Bauer, R., Olesch, C., Fuhrmann, D. C., Fink, A. F., Dehne, N., Jain, A., Ebersberger, I., Schmid, T., & Brüne, B. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23103 · Cited by 24

Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma

Liang, T., Song, Y., Gu, L., Wang, Y., & Ma, W. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s418837 · Cited by 24

Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors

Alvarez, R., Mandal, D., & Chittiboina, P. (2021) · Cells · doi:10.3390/cells10112913 · Cited by 23

Advances of HIF‑1α/glycolysis axis in non‑small cell lung cancer (Review)

Shi, Y., Lin, X., Wang, J., Zhou, Z., Chen, S., & Chen, G. (2024) · Oncology Reports · doi:10.3892/or.2024.8714 · Cited by 24

Relación entre apnea del sueño y cáncer

Martínez‐García, M. Á., Campos‐Rodríguez, F., Almendros, I., & Farré, R. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2015.02.002 · Cited by 22

The effect of combining Endostar with radiotherapy on blood vessels, tumor-associated macrophages, and T cells in brain metastases of Lewis lung cancer

Peng, L., Wang, Y., Fei, S., Wei, C., Tong, F., Wu, G., Ma, H., & Dong, X. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-500 · Cited by 22

Importance of the interaction between immune cells and tumor vasculature mediated by thalidomide in cancer treatment (Review)

Wang, X., Shen, Y., Li, S., Lv, M., Zhang, X., Yang, J., Wang, F., & Yang, J. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2724 · Cited by 22

Interleukin-15 Signaling in HIF-1α Regulation in Natural Killer Cells, Insights Through Mathematical Models

Coulibaly, A., Bettendorf, A., Kostina, E., Figueiredo, A. S., Velásquez, S. Y., Bock, H.-G., Thiel, M., Lindner, H. A., & Barbarossa, M. V. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02401 · Cited by 22

Relationship Between Sleep Apnea and Cancer

Martínez‐García, M. Á., Campos‐Rodríguez, F., Almendros, I., & Farré, R. (2015) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2015.02.034 · Cited by 24

An outline of main factors of drug resistance influencing cancer therapy

Frączek, N., Bronisz, I., Pietryka, M., Kępińska, D., Strzała, P., Mielnicka, K., Korga-Plewko, A., & Dudka, J. (2016) · Journal of Chemotherapy · doi:10.1080/1120009x.2016.1218158 · Cited by 21

Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments

Shin, S.-W., Yang, K., Lee, M., Moon, J., Son, A.-R., Kim, Y., Choi, S., Kim, D.-H., Choi, C., Lee, N., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052637 · Cited by 20

Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma

Zhang, W., Lyu, P., Andreev, D., Jia, Y., Zhang, F., & Bözec, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.974851 · Cited by 20

Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma

Dal Molin, M., Brant, A., Blackford, A. L., Griffin, J. F., Shindo, K., Barkley, T., Rezaee, N., Hruban, R. H., Wolfgang, C. L., & Goggins, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0164195 · Cited by 19

The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness

Neophytou, C., Stylianopoulos, T., & Mpekris, F. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-025-00017-3 · Cited by 20

A comprehensive review of the anticancer effects of decursin

Chu, Y., Yuan, Q., Jiang, H., Wu, L., Xie, Y., Zhang, X., & Li, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1303412 · Cited by 19

Defining and targeting macrophage heterogeneity in the mammary gland and breast cancer

Elfstrum, A. K., Bapat, A. S., & Schwertfeger, K. L. (2024) · Cancer Medicine · doi:10.1002/cam4.7053 · Cited by 22

c-Src and Neural Wiskott-Aldrich Syndrome Protein (N-WASP) Promote Low Oxygen-Induced Accelerated Brain Invasion by Gliomas

Tang, Z., Araysi, L. M., & Fathallah‐Shaykh, H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075436 · Cited by 19

Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.

Zhang, L., Ye, S., Li, Z.-L., Ma, G., Chen, S. P., He, J., Liu, W. L., Xie, D., Zeng, Y.-X., & Li, J. (2014) · PubMed Central · Cited by 18

Posttranscriptional and Translational Control of Gene Regulation in CD4+ T Cell Subsets

Istomine, R., Pavey, N., & Piccirillo, C. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501337 · Cited by 18

The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)

Glicksman, R., Chaudary, N., Pintilie, M., Leung, E., Clarke, B. A., Sy, K., Hill, R. P., Han, K. C.-Z., Fyles, A., & Milosevic, M. (2017) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2017.08.002 · Cited by 18

Prognostic value of peritumoral heat-shock factor-1 in patients receiving resection of hepatocellular carcinoma

Jb, Z., Guo, K., Sun, H.-C., Zhu, X.-D., Zhang, B., Zh, L., Bh, Z., Liu, Y.-K., Ren, Z.-G., & Fan, J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.488 · Cited by 17

Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.

Jiang, H., Tai, Z., Chen, Z., Zhu, Q., & Bao, L. (2021) · PubMed Central · Cited by 15

An anisotropic photocatalytic agent elicits robust photoimmunotherapy through plasmonic catalysis-mediated tumor microenvironment modulation

Wang, N., Li, P., Zhao, J., Liu, Y., Hu, X., Li, F., & Li, F. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101827 · Cited by 16

Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma

Jumaniyazova, E. D., Lokhonina, А. V., Dzhalilova, D. S., Kosyreva, A. M., & Fatkhudinov, T. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111616 · Cited by 19

Multi-omics characterization and validation of invasiveness-related molecular features across multiple cancer types

Bi, G., Liang, J., Zheng, Y., Li, R., Zhao, M., Huang, Y., Zhan, C., Xu, S., & Fan, H. X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02773-x · Cited by 15

Harnessing innate immunity against glioblastoma microenvironment

Zhang, W., Zhang, W., Wu, H., & Han, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1648601 · Cited by 15

Heterogeneity of the tumor immune microenvironment and clinical interventions

Jin, Z., Zhou, Q., Cheng, J., Jia, Q., & Zhu, B. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1015-9 · Cited by 14

Identification of prognostic hypoxia-related genes signature on the tumor microenvironment in esophageal cancer

Tan, L., Cheng, D., Wen, J., Huang, K., & Zhang, Q. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021384 · Cited by 15

Hypoxia Inducible Factor 1: A Urinary Biomarker of Kidney Disease

Movafagh, S., Raj, D. S., Sanaei‐Ardekani, M., Bhatia, D., Vo, K. T., Mahmoudieh, M., Rahman, R., Kim, E., & Harralson, A. (2017) · Clinical and Translational Science · doi:10.1111/cts.12445 · Cited by 14

Immunotherapy Following Regional Chemotherapy Treatment of Advanced Extremity Melanoma

Jiang, B. S., Beasley, G. M., Speicher, P. J., Mosca, P. J., Morse, M. A., Hanks, B. A., Salama, A. K. S., & Tyler, D. S. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3671-0 · Cited by 14

HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression

Harashima, N., Takenaga, K., Akimoto, M., & Harada, M. (2017) · Oncotarget · doi:10.18632/oncotarget.17157 · Cited by 13

EGFR Inhibition by Cetuximab Modulates Hypoxia and IFN Response Genes in Head and Neck Squamous Cell Carcinoma

Chaudhary, R., Slebos, R. J. C., Noel, L. C., Song, F., Poole, M. I., Hoening, D. S., Hernandez-Prera, J. C., Conejo-Garcia, J. R., Guevara-Patino, J. A., Wang, X., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0443 · Cited by 13

Targeting PFKFB3 in the Endothelium for Cancer Therapy

Yang, Q., & Hou, P. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.008 · Cited by 13

Spleen tyrosine kinase regulates crosstalk of hypoxia-inducible factor-1α and nuclear factor (erythroid-derived2)-like 2 for B cell survival

Jang, J.-W., Park, S., & Moon, E. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107509 · Cited by 13

Spatial interplay of tissue hypoxia and T-cell regulation in ductal carcinoma in situ

Sobhani, F., Muralidhar, S., Hamidinekoo, A., Hall, A. H. S., King, L. M., Marks, J. R., Maley, C. C., Horlings, H. M., Hwang, E. S., & Yuan, Y. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00419-9 · Cited by 11

Insights regarding novel biomarkers and the pathogenesis of primary colorectal carcinoma based on bioinformatic analysis

Wang, Y.-R., Meng, L., Su, F., Qiu, Y., Shi, J., Xu, X., & Luo, Q. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107229 · Cited by 12

A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications

Hacker, L., Sarsam, E., Conway, S. J., & Hammond, E. M. (2025) · Molecular Oncology · doi:10.1002/1878-0261.70151 · Cited by 13

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

Nowosielski, M., Gorlia, T., Bromberg, J. E. C., Sahm, F., Harting, I., Kickingereder, P., Brandes, A. A., TAPHOORN, M. J. B., Taal, W., Dômont, J., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007643 · Cited by 11

Isolated limb infusion as a model to test new agents to treat metastatic melanoma

Lidsky, M. E., Speicher, P. J., Jiang, B. S., Tsutsui, M., & Tyler, D. S. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23502 · Cited by 11

The unfolding story of dying tumor cells during cancer treatment

He, S., Huang, Q., & Cheng, J. Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1073561 · Cited by 10

Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents

Xiong, Z., Huang, W., Zhong, W., Fu, J., Feng, J., Wang, X., & Ling, F. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.900005 · Cited by 10

Hypoxia in Melanoma: Using Optical Spectroscopy and EF5 to Assess Tumor Oxygenation Before and During Regional Chemotherapy for Melanoma

Speicher, P. J., Beasley, G. M., Jiang, B. S., Lidsky, M. E., Palmer, G. M., Scarbrough, P. M., Mosca, P. J., Dewhirst, M. W., & Tyler, D. S. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3222-0 · Cited by 10

Breaking the crosstalk of the cellular tumorigenic network: Hypothesis for addressing resistances to targeted therapies in advanced NSCLC

Langhammer, S., & Scheerer, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16674 · Cited by 9

Oxygen regulates ILC3 antigen presentation potential and pregnancy-related hormone actions

Einenkel, R., Ehrhardt, J., Zygmunt, M., & Muzzio, D. O. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00979-2 · Cited by 10

Breaking the immune desert: Strategies for overcoming the immunological challenges of pancreatic cancer

Wang, T., Song, W., Tang, Y., Yi, J., & Pan, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189353 · Cited by 9

Hypoxia, Angiogenesis and Mechanisms for Invasion of Malignant Gliomas

Province, P., Corinne, E. G., Han, X., Louis, N., & Fathallah, H. (2013) · InTech eBooks · doi:10.5772/53298 · Cited by 7

Mechanisms of Altered Immune Response in Skin Melanoma.

Fruntealată, R.-F., Marius, M., Boboc, I. K. Ş., Mitran, S. I., Ciurea, M. E., & Stoica, G. A. (2023) · PubMed Central · doi:10.12865/chsj.49.03.01 · Cited by 8

Oligoclonal tumor-specific CD8 T-cell revival and IRE1α/XBP1-GDF15-mediated immunosuppressive niches determine neoadjuvant chemoimmunotherapy efficacy in cervical cancer

Cao, G., Wang, Y., Zeng, H., Zhi, Y., Guo, Y., Xu, M., Ruan, Y., Wang, Y., Xiao, Y., Lu, J., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012630 · Cited by 8

Multiview Clustering on PPI Network for Gene Selection and Enrichment from Microarray Data

Swarnkar, T., Simões, S. N., Martins, D., Anura, A., Brentani, H., Hashimoto, R. F., & Mitra, P. (2014) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe.2014.33 · Cited by 7

Sleep Disorders and Cancer

Martínez‐García, M. Á., Campos‐Rodríguez, F., & Almendros, I. (2016) · Current Sleep Medicine Reports · doi:10.1007/s40675-016-0034-3 · Cited by 7

Clinical activity of immunotherapy-based combination first-line therapies for metastatic renal cell carcinoma: the right treatment for the right patient

Borchiellini, D., & Maillet, D. (2022) · Bulletin du Cancer · doi:10.1016/s0007-4551(22)00234-x · Cited by 7

Transcriptional regulation and alternative splicing reveal the molecular strategies of Bombay duck Harpadon nehereus to hypoxia

Sun, Z., Wang, L., Kong, Y., Sun, J., & Kang, B. (2024) · Fisheries Science · doi:10.1007/s12562-024-01753-6 · Cited by 4

Biopterin metabolism and nitric oxide recoupling in cancer

Clark, G. C., Lai, A., Agarwal, A., Liu, Z., & Wang, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1321326 · Cited by 4

Imaging Metabolic Processes to Predict Radiation Responses

Naz, S., Kishimoto, S., Mitchell, J. B., & Krishna, M. C. (2018) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2018.10.004 · Cited by 4

The Future Liver Remnant in Patients Undergoing the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Maintains the Immunological Components of a Healthy Organ

Anantha, R. V., Shaler, C. R., Meilleur, C. E., Parfitt, J. R., Haeryfar, S. M. M., & Hernandez‐Alejandro, R. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00032 · Cited by 4

Hypoxia and Gene Expression

Bosco, M. C., & Varesio, L. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_5 · Cited by 3

Harnessing the Power of Nanomaterials to Alleviate Tumor Hypoxia in Favor of Cancer Therapy

Rashidzadeh, H., Mozafari, F., Ghaffarlou, M., Barsbay, M., Ramazani, A., Abazari, M., Rahmati, M.-A., Anwar, H., Sharma, S. K., & Danafar, H. (2022) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-031-04071-9_5 · Cited by 3

Novel Strategies in Radiotherapy to Reduce Hypoxia Using Nanomaterials

Srivastava, A., Prajapati, D., Singh, S., & Jain, T. (2023) · Smart nanomaterials technology · doi:10.1007/978-981-99-1718-1_7 · Cited by 3

Differential effects of agonistic 4-1BB (CD137) monoclonal antibody on the maturation and functions of hypoxic dendritic cells

Shang, Q., Dong, Z., Liu, C., Bai, Y., Guo, C., Zhang, L., & Wang, Q. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.10.012 · Cited by 3

Echinocystic acid in Momordica charantia L. exosome-like nanovesicles attenuates dengue virus-induced vascular leakage associated inflammatory mediators through macrophage metabolic reprogramming and HIF-1α/p300-CBP interaction

Liu, H., He, J., Xu, L., Chen, Y., Wang, X., Pang, X., Yang, H., Liang, L., Chen, S., & Li, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1653689 · Cited by 2

Emerging Role of Hypoxia-Induced Autophagy in Cancer Immunotherapy

Janji, B., Noman, M. Z., Viry, E., Hasmim, M., Messai, Y., Berchem, G., Mami‐Chouaib, F., & Chouaı̈b, S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405529-2.00017-2 · Cited by 3

Influencia de la hipoxia sobre el metabolismo óseo. Rol central del factor inducible por hipoxia

Aguirre-Siancas, E. E. (2014) · Anales de la Facultad de Medicina · doi:10.15381/anales.v74i4.2706 · Cited by 2

CAR-T Cells: Next Generation Cancer Therapeutics

Balakrishnan, A. (2018) · Journal of the Indian Institute of Science · doi:10.1007/s41745-018-0062-8 · Cited by 2

Combination of pembrolizumab and axitinib: a new gold standard in the first-line therapy for metastatic clear-cell renal-cell carcinoma?

Gafanov, R. A., Dzidzaria, A. G., Борисович, К. И., & Фастовец, С. В. (2020) · Cancer Urology · doi:10.17650/1726-9776-2020-16-3-29-37 · Cited by 2

Tumor Angiogenesis

Heymach, J. V., Zurita‐Saavedra, A., Kopetz, S., Cascone, T., Nilsson, M. B., & Guijarro, I. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm017.pub2 · Cited by 2

Current Challenges and Potential Strategies for Designing a New Generation of Chimeric Antigen Receptor-T cells with High Anti-tumor Activity in Solid Tumors

Khankishiyev, D. S., Gülden, G., Sert, B., & Tastan, C. (2023) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-023-00043-0 · Cited by 1

Understanding the relationship between silicone implants, tumor antigens, and breast cancer risk: An immunological study in rats

Zhou, Y., Li, Z., Wang, G., Yu, H., Zhou, Y., Li, Y., He, Y., Dai, H., He, Y., & Li, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113991 · Cited by 1

Tumor Angiogenesis and Lymphangiogenesis: Microenvironmental Soil for Tumor Progression and Metastatic Dissemination

Paupert, J., de Velde, M. V., Kridelka, F., & Noël, A. (2014) · Springer eBooks · doi:10.1007/978-2-8178-0466-8_13 · Cited by 1

Tratamiento del cáncer de riñón metastásico

Dumont, C., Flippot, R., Bonnet, C., Gauthier, H., Albiges, L. K., & Culine, S. (2022) · EMC - Urología · doi:10.1016/s1761-3310(22)46756-9 · Cited by 1

Development and experimental verification of a prognosis model for hypoxia- and lactate metabolism-associated genes in HNSCC

Dai, Y., Chen, X., Sui, X., Li, Y., Xin, J., Zou, J., Wang, R., & Liu, Z. (2025) · Medicine · doi:10.1097/md.0000000000042665 · Cited by 1

Cancer Immunotherapy

Ajina, R., Aldeghaither, D. S., Jablonski, S. A., & Weiner, L. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12426-6 · Cited by 2

Pleiotropic Action of Selenium in the Prevention and Treatment of Cancer, and Related Diseases

Rustum, Y. M. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-693-6 · Cited by 1

Surviving Stress with the Tumour Microenvironment: Understanding Complex Cell - Cell Interactions

Dawson, R. (2021) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.15102033 · Cited by 2

Surviving Stress with the Tumour Microenvironment: Understanding Complex Cell - Cell Interactions

Dawson, R. (2021) · doi:10.26686/wgtn.15102033.v1 · Cited by 1

Bioinformatic analysis of N6-methyladenosine, 5-methylcytosine, and N1-methyladenosine co-regulation patterns and validation of NSUN6 as a protective protein in colon cancerPreprint

Xie, W., Sun, Z. Q., & Fu, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3842256/v1 · Cited by 1

The role of hypoxia and complement receptor 2 or toll-like receptor 2 on B1 B cell effector function

Knights, K. (2013) · K-State Research Exchange (Kansas State University)

Aiming the Immune System to Improve the Antitumor Efficacy of Radiation Therapy

Guo, C., Harris, T., & Wang, X. (2016) · Springer eBooks · doi:10.1007/978-3-319-45594-5_7

Obstructive Sleep Apnea and Cancer

Kirisoglu, C. (2016) · Journal of Turkish Sleep Medicine · doi:10.4274/jtsm.216

REOVIRUS-DRIVEN MYELOID CELLS IN ONCOLYTIC VIRUS THERAPY AND INFECTION

Clements, D. R. (2018) · DalSpace (Dalhousie University)

Asociación entre cáncer y síndrome de apneas-hipopneas del sueño

Perera, D. E. C. (2020) · Gredos (University of Salamanca) · doi:10.14201/gredos.144169

TGF-β inhibition combined with cytotoxic nanomedicine normalizes the tumor microenvironment and improves immune checkpoint inhibition therapy

Stylianopoulos, T., Panagi, M., Voutouri, C., Mpekris, F., Martin, J. D., Kataoka, K., & Cabral, H. (2020) · International Online Conference on Nanomaterials (IOCN) · doi:10.3390/iocn2020-07934

Sirtuin signaling in hematologic malignancies

Denu, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00012-7

Prise en charge du cancer du rein métastatique

Dumont, C., Flippot, R., Bonnet, C., Gauthier, H., Albiges, L. K., & Culine, S. (2021)

The host response to hypoxia in the critically ill

Raju, R. P., & Chaudry, I. H. (2016) · doi:10.1093/med/9780199600830.003.0305

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Nayak, L., Molinaro, A. M., Peters, K. B., Clarke, J. L., Jordan, J. T., de Groot, J., Nghiemphu, L., Kaley, T. J., Colman, H., McCluskey, C. S., et al. (2023) · doi:10.1158/1078-0432.c.6530168

Data from Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma

Nayak, L., Molinaro, A. M., Peters, K. B., Clarke, J. L., Jordan, J. T., de Groot, J., Nghiemphu, L., Kaley, T. J., Colman, H., McCluskey, C. S., et al. (2023) · doi:10.1158/1078-0432.c.6530168.v1

Immune Response Regulation in the Tumor Microenvironment by Hypoxia

Labiano, S., Palazón, A., & Melero, I. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.02.009 · Cited by 155

Hypoxia-inducible factors as key regulators of tumor inflammation

Mamlouk, S., & Wielockx, B. (2013) · International Journal of Cancer · doi:10.1002/ijc.27901 · Cited by 61

The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment

Chouaı̈b, S., Umansky, V., & Kiéda, C. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.73874 · Cited by 45

Hypoxia Compromises Anti-Cancer Immune Responses

Multhoff, G., & Vaupel, P. W. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34461-0_18 · Cited by 179

Hypoxia-inducible factors: a central link between inflammation and cancer

Triner, D., & Shah, Y. M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84430 · Cited by 199